Generic Lovenox

This forum made possible through the generous support of SDN members, donors, and sponsors. Thank you.
Its Z

Its Z

Retired
10+ Year Member
Joined
May 15, 2010
Messages
4,849
Reaction score
165
Points
4,691
  1. Pharmacist
Advertisement - Members don't see this ad
It happened today.
 
I rode it twice in 2.5 years. Bought when it crashed when the FDA declined approval in Nov 2007 for $5. Then sold when it hit $19. Got back in at $10 or so...sat on it... was looking at it this morning and noticed it went from $11.38 to $25.5. Got out at $24.4. Done.
 
Its Z said:
I rode it twice in 2.5 years. Bought when it crashed when the FDA declined approval in Nov 2007 for $5. Then sold when it hit $19. Got back in at $10 or so...sat on it... was looking at it this morning and noticed it went from $11.38 to $25.5. Got out at $24.4. Done.
Click to expand...

👍👍
 
If you dont mind me asking, how much were you into it?
 
Advertisement - Members don't see this ad
I was under the impression that there was no generic lovenox because other companies could not figure out how to make it properly. Did the FDA just say 'this is close enough' or did Sandoz figure it out?

I could be completely wrong...but I thought that if you didn't make lovenox properly, you would end up with Fragmin. Can somebody shed some light on this for me?
 
That is the topic of bioeuquivalence.

They're equivalent though Momenta is calling it M-Enoxaparin.
 
CUninja said:
I was under the impression that there was no generic lovenox because other companies could not figure out how to make it properly. Did the FDA just say 'this is close enough' or did Sandoz figure it out?

I could be completely wrong...but I thought that if you didn't make lovenox properly, you would end up with Fragmin. Can somebody shed some light on this for me?
Click to expand...

Sanofi Rep told you that didn't he/she?

:meanie:
 
Advertisement - Members don't see this ad
SpirivaSunrise said:
You ever get anything out of IDMI?


Posted via Mobile BlackBerry Device
Click to expand...



You know, I think I did....but I can't go back beyond 2 years in my txn history....
I don't own any today and I can't quite remember the details.
 
Its Z said:
You know, I think I did....but I can't go back beyond 2 years in my txn history....
I don't own any today and I can't quite remember the details.
Click to expand...

I just remember talking about those two w/ you...and I still have them in my "for fun" portfolio. Though looks like IDMI was bought out...


Posted via Mobile BlackBerry Device
 
I'm going to have to redo the E section for this. Where am I going to put all the boxes?
 
just replace brand with generic.
 
Advertisement - Members don't see this ad
crazybob said:
Between enfuvirtide and entacapone?
Click to expand...
It'll actually be right after enablex. The issue is the height of the shelves, and also, there is not a lot of extra room in that area.
Lovenox is with the Ls. We don't put generic and brand next to each other.
 
Drugs should be arranged by generic names.. jmo.
 
I've had PMs regarding drug stocks... so I'll just put the response here.


I'm by no means an expert in stock market.

I leave long term investments in mutual funds. But I do tool around with day trading once in a while and those involve stocks. Human emotion plays the major part in riding the stock to the peak and you have to make quick decisions when the frenzy starts.

To answer your question, no not all generic approval garner interest of investors. But "news" is the key. If it's a good news, people start to buy thereby driving up the cost. With bad news, stock holders start to dump thereby decreasing the cost.

Lovenox is typically the #1 or #2 drug cost at most hospitals in the US...I know this because I work with different hospitals throughout the country. So it's a huge deal for the FDA to approve the generic version. My risk was that there were 2 companies with generic application; Momenta backed by Sandoz/Novartis and Amphastar backed by Teva. The reality of it is that since Amphastar is a privately held company, I couldn't buy their stock anyways. Momenta was a publicly traded company. And the stock plummeted when the FDA denied the generic enoxaparin application in Nov 2007. For me, it was a no brainer that the FDA would eventually approve the generic ANDA. The only risk I had to take was will it be Momenta or Amphastar. Also, I knew it would be a long term hold but I watched it daily.

Now, I've had other drug company stocks who were involved with Phase II and III trials...typically smaller company and like clockwork whenever there was a good news, stock would jump 50% to 100%. And I was typically lucky and would usually sell at peak.

Because I typically work from home, I can watch these stocks and day trade. If you don't, then you'll miss out.

Another thing is that we have a buddy system where few of my colleagues and I watch stocks and always inform the other when something is up.

It's a gamble and I don't do it often.

Now with Momenta, I will get back in it when the dust settles and the price drops to $10 to $15... because I know Momenta also has a generic version of Copaxone which will get approved in a few years. It won't peak as much as it did with lovenox but it will be a nice run again.

So the key here is to find a company with solid product and wait for the good news.

Be on the lookout for biotech companies working on innovative stuff... Phase III positive outcome will usually mean a rise in price...FDA approval for a treatment of significant disease mean a massive run up on the day... time it and sell. With smaller companies, good news also comes in a form of "buy out" by a larger company. As Momenta was enjoying a 90% rise in stock price, in the same building there were ecstatic Genzyme stock holders partying it up with the news of Sanofi potentially buying them out. Genzyme stock rose $10 per share. Oh the irony as Sanofi (maker of Lovenox) dropped almost 5% on the news of generic enoxaparin.

With the news of generic enoxaparin approval, Teva took a dump because now it looks like the FDA will be approving complex biologicals as if they are generic drugs. This means Teva's Copaxone (complex molecule) is now vulnerable to going generic when the patent expires... funny Momenta holds that key.

I have time to time posted different stock news on SDN.... it never really attracted much interest from anyone. That's ok. But I'm willing to read about drug stocks if posted here.
 
Its Z said:
Drugs should be arranged by generic names.. jmo.
Click to expand...

I used to think so. Now I think to many sound alike drugs next to each other increases the risk of error.....

Heck, when I started out, things were arranged by company to make ordering easier. Since almost nobody buys direct anymore that's out the window....
 
Old Timer said:
I used to think so. Now I think to many sound alike drugs next to each other increases the risk of error.....
Click to expand...

That's what "Look Alike Sound Alike" drug labels are for.
 
Its Z said:
I've had PMs regarding drug stocks... so I'll just put the response here.


I'm by no means an expert in stock market.

I leave long term investments in mutual funds. But I do tool around with day trading once in a while and those involve stocks. Human emotion plays the major part in riding the stock to the peak and you have to make quick decisions when the frenzy starts.

To answer your question, no not all generic approval garner interest of investors. But "news" is the key. If it's a good news, people start to buy thereby driving up the cost. With bad news, stock holders start to dump thereby decreasing the cost.

Lovenox is typically the #1 or #2 drug cost at most hospitals in the US...I know this because I work with different hospitals throughout the country. So it's a huge deal for the FDA to approve the generic version. My risk was that there were 2 companies with generic application; Momenta backed by Sandoz/Novartis and Amphastar backed by Teva. The reality of it is that since Amphastar is a privately held company, I couldn't buy their stock anyways. Momenta was a publicly traded company. And the stock plummeted when the FDA denied the generic enoxaparin application in Nov 2007. For me, it was a no brainer that the FDA would eventually approve the generic ANDA. The only risk I had to take was will it be Momenta or Amphastar. Also, I knew it would be a long term hold but I watched it daily.

Now, I've had other drug company stocks who were involved with Phase II and III trials...typically smaller company and like clockwork whenever there was a good news, stock would jump 50% to 100%. And I was typically lucky and would usually sell at peak.

Because I typically work from home, I can watch these stocks and day trade. If you don't, then you'll miss out.

Another thing is that we have a buddy system where few of my colleagues and I watch stocks and always inform the other when something is up.

It's a gamble and I don't do it often.

Now with Momenta, I will get back in it when the dust settles and the price drops to $10 to $15... because I know Momenta also has a generic version of Copaxone which will get approved in a few years. It won't peak as much as it did with lovenox but it will be a nice run again.

So the key here is to find a company with solid product and wait for the good news.

Be on the lookout for biotech companies working on innovative stuff... Phase III positive outcome will usually mean a rise in price...FDA approval for a treatment of significant disease mean a massive run up on the day... time it and sell. With smaller companies, good news also comes in a form of "buy out" by a larger company. As Momenta was enjoying a 90% rise in stock price, in the same building there were ecstatic Genzyme stock holders partying it up with the news of Sanofi potentially buying them out. Genzyme stock rose $10 per share. Oh the irony as Sanofi (maker of Lovenox) dropped almost 5% on the news of generic enoxaparin.

With the news of generic enoxaparin approval, Teva took a dump because now it looks like the FDA will be approving complex biologicals as if they are generic drugs. This means Teva's Copaxone (complex molecule) is now vulnerable to going generic when the patent expires... funny Momenta holds that key.

I have time to time posted different stock news on SDN.... it never really attracted much interest from anyone. That's ok. But I'm willing to read about drug stocks if posted here.
Click to expand...

I've never done any day trading (for the obvious reasons). Have you ever tried it by putting in a stop order to avoid having to babysit it?
 
Its Z said:
That's what "Look Alike Sound Alike" drug labels are for.
Click to expand...

I feel like the tallman lettering loses its effect when so many drugs have it...safety fatigue, I suppose.

I liked working at a store that had everything arranged by brand name, made learning the generics a whole lot easier.
 
SpirivaSunrise said:
I've never done any day trading (for the obvious reasons). Have you ever tried it by putting in a stop order to avoid having to babysit it?
Click to expand...

I typically put in a 1 day stop order when I purchase. Also, when I'm just trying to dump a stock, I use a stop order.

But I rarely put in a stop order for a stock in a frenzy. I had originally said if MNTA hits $20, I would sell. Yet if I put in a stop order at $20, then I would have missed out an additional profit because you just never know how high it will rise.
 
Its Z said:
I typically put in a 1 day stop order when I purchase. Also, when I'm just trying to dump a stock, I use a stop order.

But I rarely put in a stop order for a stock in a frenzy. I had originally said if MNTA hits $20, I would sell. Yet if I put in a stop order at $20, then I would have missed out an additional profit because you just never know how high it will rise.
Click to expand...

True, but it would be an option for those who can't be following it each and every day...no? Because same could be said if it had hit $28 after you sold at $24. You just never know, yet sell @ $20 would have been a worthwhile gain too - especially for someone not watching consistently.

Anyways...my 401K is kicking a**. By no means going to mess with what I'm doing with that. I haven't put any more directly into stock since 2001, but may start to again with some side $. My Mom does well in it...her sales in Apple stock alone will pay for sister's Rx school.
 
Advertisement - Members don't see this ad
SpirivaSunrise said:
True, but it would be an option for those who can't be following it each and every day...no? Because same could be said if it had hit $28 after you sold at $24. You just never know, yet sell @ $20 would have been a worthwhile gain too - especially for someone not watching consistently.
Click to expand...


The initial spike tends to top out quickly..

You needs you an iphone or a quick online access to trade..so when a buddy sends you a "sell" text, you can act quickly.
 
Its Z said:
The initial spike tends to top out quickly..

You needs you an iphone or a quick online access to trade..so when a buddy sends you a "sell" text, you can act quickly.
Click to expand...

Just because I like Apple stock...doesn't mean I like Apple products. 😛
 
SpirivaSunrise said:
Just because I like Apple stock...doesn't mean I like Apple products. 😛
Click to expand...

Luck has a lot to do with it. One guy sold while back and never got in. He was crying. The other dood in CA sold as soon as I told him. The other dood was in a meeting and got on the news 2 hours behind. The other dood was in a plane and didn't get my text till the stock market closed.
 
Its Z said:
Luck has a lot to do with it. One guy sold while back and never got in. He was crying. The other dood in CA sold as soon as I told him. The other dood was in a meeting and got on the news 2 hours behind. The other dood was in a plane and didn't get my text till the stock market closed.
Click to expand...

See! So I'm still thinking stop order would be the way to go. I mean...there's got to be more of a downfall other than you'll miss the peak.

Posted via Mobile BlackBerry Device
 
SpirivaSunrise said:
See! So I'm still thinking stop order would be the way to go. I mean...there's got to be more of a downfall other than you'll miss the peak.

Posted via Mobile BlackBerry Device
Click to expand...

Quit trying to justify your scenario... be a man and work from home!

:meanie:
 
SpirivaSunrise said:
I'm calling HR! 😛

One day...gonna shoot for a director pos.

Posted via Mobile BlackBerry Device
Click to expand...

Directors get to work from home?

Be a man! Shoot for a VP pos!!
 
SpirivaSunrise said:
Directors work from home...there are only 2 females in the whole company. They're actually looking into why that is.

VP has an office at corporate HQ.
Click to expand...

Because you work for buncha pigs.
 
Advertisement - Members don't see this ad
You must log in or register to reply here.

Similar threads

S
"Billionaire Mark Cuban Launches Online Pharmacy With Generic Drugs at Affordable Prices."
Replies
12
Views
2K
Splenda88
S
S
Manufacturing Locations of Generic Drugs in EU
Replies
2
Views
734
deleted820760
D
genesis09
Generic Advair
Replies
4
Views
1K
WVUPharm2007
WVUPharm2007
S
Generic Pregabalin
Replies
2
Views
1K
ValeRx
ValeRx
WVUPharm2007
Generic Proair came in today...
Replies
13
Views
2K
CetiAlphaFive
CetiAlphaFive
Top Bottom